Trials in Relapsed/Refractory Multiple Myeloma

A conversation on current trails with multiple myeloma including CANDOR and IKEMA; understanding the role of anti-CD38 monoclonal antibody in the treatment of relapsed/refractory multiple myeloma.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive